In Vivo Inhibitory Effect of Suberoylanilide Hydroxamic Acid Combined With Sorafenib on Human Hepatocellular Carcinoma Cells

Brazilian Journal of Pharmaceutical Sciences - Brazil
doi 10.1590/s2175-97902019000318254
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Synergistic Effects of Combined Treatment With Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and TRAIL on Human Breast Cancer Cells

Scientific Reports
Multidisciplinary
2016English

Cytotoxicity of Sorafenib in Human Hepatocellular Carcinoma Cells

Al-Azhar Journal of Pharmaceutical Sciences
2015English

Cardiomyogenic Differentiation of Human Dental Follicle-Derived Stem Cells by Suberoylanilide Hydroxamic Acid and Their in Vivo Homing Property

International Journal of Medical Sciences
Medicine
2016English

Triclosan Treatment Decreased the Antitumor Effect of Sorafenib on Hepatocellular Carcinoma Cells

OncoTargets and Therapy
OncologyPharmacology
2018English

Suberoylanilide Hydroxamic Acid Induces Limited Changes in the Transcriptome of Primary CD4+ T Cells

AIDS
Infectious DiseasesAllergyImmunology
2013English

Pharmacokinetics and Pharmacodynamics of Suberoylanilide Hydroxamic Acid in Cats

Journal of Veterinary Pharmacology and Therapeutics
VeterinaryPharmacology
2013English

Protective Effect of Suberoylanilide Hydroxamic Acid Against Lipopolysaccharide-Induced Liver Damage in Rodents

Journal of Surgical Research
Surgery
2015English

Suberoylanilide Hydroxamic Acid (SAHA) Changes microRNA Expression Profiles in A549 Human Non-Small Cell Lung Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2009English

Sorafenib Combined With Hepatectomy in Patients With Intermediate-Stage and Advanced Hepatocellular Carcinoma

Archives of Medical Science
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy